D-0881-2023 Class II Terminated
FDA drug recall D-0881-2023 was initiated by Homeocare Laboratories, Inc. on June 5, 2023 and is designated Class II. Reason for recall: cGMP deviations The recall status is terminated (terminated September 16, 2024). Affected quantity: 2,376 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- July 5, 2023
- Initiation Date
- June 5, 2023
- Termination Date
- September 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,376 bottles
Product Description
Arnica 7 Cream, net wt 2 oz (56.7g), Manufactured for: Brazmedics, LLC, New York, NY 10021 UPC 8 60208 00181 6
Reason for Recall
cGMP deviations
Distribution Pattern
Product was distributed USA nationwide.
Code Information
Lot # 2446, exp. Mar-24